The Kattan and Steyerberg nomograms outperformed other models for predicting the probability of insignificant disease in patients with Gleason score ≤6 prostate cancers diagnosed upon extended transrectal biopsy with ≥10 cores (n = 370). All nomograms were more accurate in identifying significant rather than insignificant disease and performed better in patients with posterior–basal tumours than in those with cancers located in the anterior and apical prostate.
ORIGINAL RESEARCH PAPER
Iremashvili, V. et al. Comparative validation of nomograms predicting clinically insignificant prostate cancer. Urology doi:10.1016/j.urology.2013.01.062
Rights and permissions
About this article
Cite this article
Best nomograms for predicting insignificant disease. Nat Rev Urol 10, 307 (2013). https://doi.org/10.1038/nrurol.2013.92
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.92